Glaukos reported $19 million in net sales in the third quarter, a 57% increase from $12.1 million reported in the same quarter of 2014, according to a press release. The increase was attributed to the continued adoption of the iStent trabecular micro-b…
VIDEO: Patient response to anti-VEGF injections could be strong predictor of outcomes to therapy
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Pravin Dugel, MD, presents analysis of raw data from DRCR.net Protocol I, in which patient response to therapy after three injections of anti-VEGF was found to be predictive of long-term outcomes of continued treatment.
CoreSource and Liazon Partner to Launch TPA Private Exchange Solution
LAKE FOREST, Ill.–(BUSINESS WIRE)–CoreSource, a national health benefits administrator, & Liazon, operator of industry-leading private benefits exchange Bright Choices®, creates a new third-party administrator (TPA) private exchange.
Ophthotech Corporation to Present at the Oppenheimer 26th Annual Healthcare Conference
NEW YORK–(BUSINESS WIRE)–Ophthotech announced today that David R. Guyer will present an overview of the Company at the Oppenheimer 26th Annual Healthcare Conference in New York City on December 8, 2015 at 8:35 a.m. ET.
Website launched with the aim of raising awareness of Dry Eye Syndrome and related co-morbidities
“Studies have shown that 98-99% of patients want information about their options,” said co-founder, chair, and executive director Natalia Warren.
Best Apps of 2015
Shamik Bafna, MD
My favorite app of 2015 is WhatsApp (whatsapp.com; WhatsApp), an instant…